Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

被引：0
|
作者：
Becker, Pamela S. [1 ,2 ,3 ]
Schmitt, Michael W. [4 ]
Xie, Zhiyi [5 ]
Carson, Andrew R. [6 ]
Patay, Bradley [6 ]
Khankhajeh, Seyed Sina [7 ]
Wei, Qi [7 ]
Hung, Ling-Hong [7 ]
Martins, Timothy [3 ]
Estey, Elihu H. [1 ]
Blau, C. Anthony [2 ,8 ]
Oehler, Vivian G. [2 ]
Yeung, Ka Yee [7 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[3] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
[4] Univ Washington, Hematol & Med Oncol, Seattle, WA 98195 USA
[5] Invivoscribe, San Diego, CA USA
[6] Genection, San Diego, CA USA
[7] Univ Washington, Inst Technol, Tacoma, WA USA
[8] Univ Washington, Ctr Canc Innovat, Seattle, WA 98195 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 27 条
  • [1] CORRELATION OF GENOMIC ANALYSIS BY MYAML™ WITH IN VITRO HIGH THROUGHPUT DRUG SENSITIVITY TESTING IN NEW DIAGNOSIS AND RELAPSED ACUTE MYELOID LEUKEMIA
    Becker, P. S.
    Schmitt, M.
    Loeb, L.
    Gu, W.
    Wei, Q.
    Xie, Z.
    Carson, A.
    Martins, T.
    Blau, C. A.
    Oehler, V.
    Yeung, K. Y.
    HAEMATOLOGICA, 2015, 100 : 365 - 366
  • [2] Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay
    Becker, Pamela S.
    Oehler, Vivian
    Estey, Elihu H.
    Martins, Timothy
    Perdue, Andrea
    David, Jodie
    Chien, Sylvia
    Hendrie, Paul C.
    Ostronoff, Fabiana
    Blau, C. Anthony
    BLOOD, 2014, 124 (21)
  • [3] High-throughput mutation analysis in acute myeloid leukemia (AML)
    Dunlap, J.
    Corless, C. L.
    Fleming, W. H.
    Braziel, R.
    Leeborg, N.
    Gatter, K.
    Loriaux, M.
    Kelemen, K.
    Kovacsovics, T.
    Fan, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] IN VITRO DRUG SENSITIVITY TEST IN THE INDIVIDUALIZED ANTI-LEUKEMIA CHEMOTHERAPY FOR THE NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Lim, S. -N.
    Lee, W. S.
    Shin, J. -G.
    Kim, E. -Y.
    Oh, M. -K.
    Shin, H. -J.
    Lee, H. S.
    Lee, S. M.
    HAEMATOLOGICA, 2017, 102 : 675 - 675
  • [5] Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia
    Lv, Wenxiu
    Chen, Tianping
    Wang, Shen
    Li, Chun
    Zhang, Bo
    Wang, Liang
    Xv, Fang
    Cao, Fang
    Wang, Jing
    Chen, Li
    Liao, Chenglin
    Li, Na
    Liu, Hongjun
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [6] Multiplex high-throughput gene mutation analysis in acute myeloid leukemia
    Dunlap, Jennifer
    Beadling, Carol
    Warrick, Andrea
    Neff, Tanaya
    Fleming, William H.
    Loriaux, Marc
    Heinrich, Michael C.
    Kovacsovics, Tibor
    Kelemen, Katalin
    Leeborg, Nicky
    Gatter, Ken
    Braziel, Rita M.
    Press, Richard
    Corless, Christopher L.
    Fan, Guang
    HUMAN PATHOLOGY, 2012, 43 (12) : 2167 - 2176
  • [7] OUTCOME OF PERSONALIZED THERAPY BASED ON HIGH-THROUGHPUT EX VIVO DRUG SCREENING IN PATIENTS WITH RELAPSED, CHEMOREFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Kontro, M.
    Pemovska, Tea
    Kulesskiy, E.
    Edgren, H.
    Eldfors, S.
    Elonen, E.
    Karjalainen, R.
    Majumder, M.
    Murumagi, A.
    Parsons, A.
    Aittokallio, T.
    Wennerberg, K.
    Kallioniemi, O.
    Porkka, K.
    HAEMATOLOGICA, 2013, 98 : 19 - 20
  • [8] Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
    P O Pietarinen
    T Pemovska
    M Kontro
    B Yadav
    J P Mpindi
    E I Andersson
    M M Majumder
    H Kuusanmäki
    P Koskenvesa
    O Kallioniemi
    K Wennerberg
    C A Heckman
    S Mustjoki
    K Porkka
    Blood Cancer Journal, 2015, 5 (5) : e309 - e309
  • [9] Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
    Pietarinen, P. O.
    Pemovska, T.
    Kontro, M.
    Yadav, B.
    Mpindi, J. P.
    Andersson, E. I.
    Majumder, M. M.
    Kuusanmaki, H.
    Koskenvesa, P.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Mustjoki, S.
    Porkka, K.
    BLOOD CANCER JOURNAL, 2015, 5
  • [10] A high-throughput platform identifies novel drug combinations towards acute myeloid leukemia therapy
    Soltis, Anthony R.
    Zhelyazkova, Boryana
    Drane, Pascal
    Eleftheriadis, Efstathios
    Ventresco, Andrew
    Weitz, David A.
    Lee, Arlinda
    Iafrate, Anthony J.
    CANCER RESEARCH, 2024, 84 (06)
123